USA - NASDAQ:NOTV - US45783Q1004 - Common Stock
The current stock price of NOTV is 1.46 USD. In the past month the price decreased by -10.98%. In the past year, price decreased by -24.16%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TMO | THERMO FISHER SCIENTIFIC INC | 24.82 | 205.16B | ||
DHR | DANAHER CORP | 28.55 | 153.94B | ||
BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 139.07 | 45.36B | ||
A | AGILENT TECHNOLOGIES INC | 25.99 | 40.15B | ||
IQV | IQVIA HOLDINGS INC | 18.01 | 35.13B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 32.13 | 27.07B | ||
WST | WEST PHARMACEUTICAL SERVICES | 39.16 | 19.60B | ||
WAT | WATERS CORP | 26.85 | 19.55B | ||
TEM | TEMPUS AI INC | N/A | 15.92B | ||
ILMN | ILLUMINA INC | 24.55 | 15.70B | ||
ICLR | ICON PLC | 14.66 | 15.08B | ||
MEDP | MEDPACE HOLDINGS INC | 39.59 | 14.96B |
Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. The company is headquartered in West Lafayette, Indiana and currently employs 1,977 full-time employees. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. The company operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
INOTIV INC
2701 Kent Ave
West Lafayette INDIANA 47906 US
CEO: Robert W. Leasure Jr.
Employees: 2026
Phone: 13174634527
The current stock price of NOTV is 1.46 USD. The price decreased by -2.67% in the last trading session.
The exchange symbol of INOTIV INC is NOTV and it is listed on the Nasdaq exchange.
NOTV stock is listed on the Nasdaq exchange.
9 analysts have analysed NOTV and the average price target is 5.61 USD. This implies a price increase of 284.25% is expected in the next year compared to the current price of 1.46. Check the INOTIV INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
INOTIV INC (NOTV) has a market capitalization of 50.15M USD. This makes NOTV a Micro Cap stock.
INOTIV INC (NOTV) currently has 2026 employees.
INOTIV INC (NOTV) has a support level at 1.37 and a resistance level at 1.52. Check the full technical report for a detailed analysis of NOTV support and resistance levels.
The Revenue of INOTIV INC (NOTV) is expected to grow by 6.5% in the next year. Check the estimates tab for more information on the NOTV EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NOTV does not pay a dividend.
INOTIV INC (NOTV) will report earnings on 2025-12-01, after the market close.
INOTIV INC (NOTV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.7).
The outstanding short interest for INOTIV INC (NOTV) is 6.86% of its float. Check the ownership tab for more information on the NOTV short interest.
ChartMill assigns a fundamental rating of 2 / 10 to NOTV. NOTV has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months NOTV reported a non-GAAP Earnings per Share(EPS) of -2.7. The EPS increased by 29.69% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -10.39% | ||
ROE | -54.92% | ||
Debt/Equity | 2.73 |
9 analysts have analysed NOTV and the average price target is 5.61 USD. This implies a price increase of 284.25% is expected in the next year compared to the current price of 1.46.
For the next year, analysts expect an EPS growth of 43.04% and a revenue growth 6.5% for NOTV